KRS Capital Management LLC decreased its stake in Veeva Systems Inc. (NYSE:VEEV – Free Report) by 9.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,190 shares of the technology company’s stock after selling 125 shares during the period. KRS Capital Management LLC’s holdings in Veeva Systems were worth $250,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Trust Co. of Vermont lifted its stake in Veeva Systems by 157.8% in the 4th quarter. Trust Co. of Vermont now owns 1,111 shares of the technology company’s stock valued at $234,000 after purchasing an additional 680 shares during the last quarter. CGN Advisors LLC lifted its stake in Veeva Systems by 11.4% in the 4th quarter. CGN Advisors LLC now owns 11,406 shares of the technology company’s stock valued at $2,398,000 after purchasing an additional 1,168 shares during the last quarter. Premier Path Wealth Partners LLC lifted its stake in Veeva Systems by 5.6% in the 4th quarter. Premier Path Wealth Partners LLC now owns 1,525 shares of the technology company’s stock valued at $321,000 after purchasing an additional 81 shares during the last quarter. Alhambra Investment Management LLC bought a new position in Veeva Systems in the 4th quarter valued at approximately $259,000. Finally, Arkadios Wealth Advisors lifted its stake in Veeva Systems by 1.9% in the 4th quarter. Arkadios Wealth Advisors now owns 3,112 shares of the technology company’s stock valued at $654,000 after purchasing an additional 58 shares during the last quarter. Institutional investors own 88.20% of the company’s stock.
Veeva Systems Stock Up 0.9 %
NYSE:VEEV traded up $1.92 during mid-day trading on Friday, hitting $216.67. 715,069 shares of the stock traded hands, compared to its average volume of 940,345. Veeva Systems Inc. has a 12-month low of $170.25 and a 12-month high of $258.93. The company has a market cap of $35.18 billion, a PE ratio of 53.50, a price-to-earnings-growth ratio of 1.91 and a beta of 0.84. The business’s 50-day moving average price is $222.68 and its 200 day moving average price is $209.23.
Analyst Ratings Changes
Check Out Our Latest Stock Analysis on Veeva Systems
Insider Transactions at Veeva Systems
In related news, insider Thomas D. Schwenger sold 1,126 shares of the company’s stock in a transaction on Friday, November 8th. The shares were sold at an average price of $240.01, for a total transaction of $270,251.26. Following the completion of the sale, the insider now directly owns 27,013 shares in the company, valued at $6,483,390.13. This represents a 4.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, SVP Jonathan Faddis sold 1,694 shares of the company’s stock in a transaction on Wednesday, December 4th. The shares were sold at an average price of $230.30, for a total transaction of $390,128.20. Following the sale, the senior vice president now owns 8,061 shares of the company’s stock, valued at $1,856,448.30. This represents a 17.37 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 10.50% of the company’s stock.
About Veeva Systems
Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.
Further Reading
- Five stocks we like better than Veeva Systems
- Retail Stocks Investing, Explained
- Top ETFs That Beat the Market in 2024 and Could Do It Again
- Stock Dividend Cuts Happen Are You Ready?
- J.B. Hunt Leads Truckers Lower: Buy Them While They’re Down?
- Why Are These Companies Considered Blue Chips?
- MarketBeat Week in Review – 01/13 – 01/17
Want to see what other hedge funds are holding VEEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Veeva Systems Inc. (NYSE:VEEV – Free Report).
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.